Zacks Investment Research upgraded shares of Halyard Health, Inc. (NYSE:HYH) from a sell rating to a hold rating in a report issued on Thursday.

According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “

Other research analysts also recently issued reports about the company. Stifel Nicolaus reiterated a buy rating and issued a $45.00 target price on shares of Halyard Health in a research note on Thursday, September 21st. BidaskClub upgraded Halyard Health from a hold rating to a buy rating in a research note on Wednesday, June 28th. Stephens upgraded Halyard Health from an equal weight rating to an overweight rating in a research note on Thursday, August 3rd. Deutsche Bank AG lifted their target price on Halyard Health from $35.00 to $42.00 and gave the company a buy rating in a research note on Thursday, August 3rd. Finally, KeyCorp reiterated a hold rating on shares of Halyard Health in a research note on Tuesday, October 17th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of $42.25.

Shares of Halyard Health (HYH) traded up 1.31% on Thursday, reaching $44.01. The company’s stock had a trading volume of 289,633 shares. The stock has a 50-day moving average price of $45.23 and a 200-day moving average price of $40.71. The company has a market capitalization of $2.06 billion, a price-to-earnings ratio of 42.32 and a beta of 1.75. Halyard Health has a 1-year low of $31.59 and a 1-year high of $46.63.

Halyard Health (NYSE:HYH) last announced its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.14. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The company had revenue of $399.20 million for the quarter, compared to the consensus estimate of $399.16 million. During the same period last year, the business posted $0.45 EPS. The company’s revenue was down .2% on a year-over-year basis. On average, equities research analysts forecast that Halyard Health will post $1.95 EPS for the current year.

WARNING: This article was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.dailypolitical.com/2017/10/22/halyard-health-inc-hyh-upgraded-at-zacks-investment-research.html.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Narwhal Capital Management acquired a new stake in shares of Halyard Health in the 3rd quarter valued at approximately $641,000. Quotient Investors LLC acquired a new stake in shares of Halyard Health in the 3rd quarter valued at approximately $203,000. Koch Industries Inc. acquired a new stake in shares of Halyard Health in the 2nd quarter valued at approximately $297,000. Sterling Capital Management LLC acquired a new stake in shares of Halyard Health in the 2nd quarter valued at approximately $631,000. Finally, Raymond James Financial Services Advisors Inc. acquired a new stake in shares of Halyard Health in the 2nd quarter valued at approximately $217,000. 91.02% of the stock is owned by institutional investors and hedge funds.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Get a free copy of the Zacks research report on Halyard Health (HYH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.